How Notified Bodies Must Actively Monitor Legacy Products
Executive Summary
New guidance sheds light on the type of auditing notified bodies need to do for legacy products and how they may best manage these duties alongside responsibilities to perform MDR audits.
You may also be interested in...
MDCG Meeting Updates Expected To Break Implementation Silence On EU IVDR
With the impending 26 May deadline for implementing the EU IVD Regulation, it is surprising that there have been no new guidances published for nearly a month now. So what is going on?
EU Regulatory Roundup, March 2024: Busy Agenda In Broad Range Of Key Areas
March was an important month for EU medtech regulation with an interesting spread of news relating to the Medical Device and IVD Regulations, the Batteries Regulation, the Artificial Intelligence Act and more.
EU’s Revised Phthalates Guideline Features New Annexes Focused On Alternatives
The effects of phthalates, plasticizers used in many medical devices, on the human endocrine system, have long been debated. But how safe are the alternatives? Updated guidelines give more insight.